Login to Your Account



Biosimilars in China: Firms await CFDA regulations this year

By Cornelia Zou
Staff Writer

Wednesday, June 4, 2014

HONG KONG – A framework of the guidelines for biosimilar approvals in China should be released in June, and work proceeds apace to have regulations in place by the end of the year, industry insiders told BioWorld Asia.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription